Home/Filings/4/0001209191-24-005012
4//SEC Filing

Knight Jeff E. 4

Accession 0001209191-24-005012

CIK 0001658247other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 6:35 PM ET

Size

5.2 KB

Accession

0001209191-24-005012

Insider Transaction Report

Form 4
Period: 2024-03-18
Knight Jeff E.
Chief Operating Officer
Transactions
  • Tax Payment

    Common Stock

    2024-03-18$38.14/sh4,283$163,35454,939 total
Footnotes (1)
  • [F1]Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on February 28, 2022 and March 1, 2023. The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.

Issuer

Crinetics Pharmaceuticals, Inc.

CIK 0001658247

Entity typeother

Related Parties

1
  • filerCIK 0001881007

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 6:35 PM ET
Size
5.2 KB